NOT-AI-15-001: Notice of a Change to Award Project Period in PAR-14-329 "Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1)"

Notice of a Change to Award Project Period in PAR-14-329 "Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1)"

Notice Number:

NOT-AI-15-001

Key Dates

Release Date: October 7, 2014

Related Announcements

PAR-14-329

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to extend the Award Project Period in PAR-14-329, titled "Limited Competition Strategic Timing of Antiretroviral Treatment (START) (UM1)", from 2 years to 3 years.

Part 2. Section II. Award Information

Currently reads:

Award Project Period

The project period is limited to 2 years.

Modified to read:

Award Project Period

The project period is limited to 3 years.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Robert C. Palmer
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-4842
Email: [email protected]